Institutional Ownership
Maze Therapeutics Inc
CUSIP 578784100COMMAZEQ1 2026
Institutional Holders
161
13F filers
Shares Held
49.88M
Aggregate institutional
Institutional Value
$1.47B
Q1 2026
Net New Holders
+22
45 new · 23 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions45
Increased58
Decreased36
Sold out23
Institutional Holders
161 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 4.57M | $136.33M | 0 | Held |
| 2 | Trv Gp IV, LLC | 4.47M | $133.55M | 0 | Held |
| 3 | Arch Venture Management, LLC | 4.12M | $122.98M | 0 | Held |
| 4 | Deep Track Capital, LP | 3.48M | $103.81M | −768.9K | Reduced |
| 5 | Janus Henderson Group PLC | 2.86M | $85.28M | −283.7K | Reduced |
| 6 | Paradigm Biocapital Advisors LP | 2.74M | $81.92M | +2.74M | New |
| 7 | Blackrock, Inc. | 2.57M | $76.73M | +283.3K | Added |
| 8 | A16z Capital Management, L.L.C. | 1.70M | $50.81M | 0 | Held |
| 9 | Venrock Adviser, LLC | 1.60M | $47.82M | +53.5K | Added |
| 10 | Alphabet Inc. | 1.39M | $41.45M | 0 | Held |
151 more institutional holders on Premium
See every fund holding Maze Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders